Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

27.81 +0.95 (+3.54%)

Delayed Quote Updated: 11:11 AM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

28 29 30 31 32 33 34 35 Next >

Jim Carmer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business' ↗

October 11, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Abbott Laboratories (NYSE: ABT) is a "very good company and will be up to the—let’s say—up to the challenge. I think that’s fair.

Via Benzinga

Consolidation In Viking Therapeutics Provides An Opportunity ↗

October 01, 2023

Viking Therapeutics Inc. (VKTX) is an innovative biotechnology company developing novel therapeutics for metabolic and endocrine diseases.

Via Talk Markets

Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday ↗

September 18, 2023

U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

3 Biotechs Compete for the Same $108-Billion-Dollar Market. Are They a Buy? ↗

August 23, 2023

NASH treatments are projected to be one of the most sought-after indications in the coming years.

Via The Motley Fool

2 Magnificient Growth Stocks I'm Buying in August ↗

August 02, 2023

These biotech stocks could markedly outperform the broader market.

Via The Motley Fool

9 Analysts Have This to Say About Viking Therapeutics ↗

July 27, 2023

Via Benzinga

Earnings Preview: Viking Therapeutics ↗

July 25, 2023

Via Benzinga

Expert Ratings for Viking Therapeutics ↗

June 27, 2023

Via Benzinga

Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It ↗

August 23, 2023

NASH is a surprisingly common ailment, and the first treatments are on the way.

Via The Motley Fool

The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023 ↗

August 16, 2023

All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 08, 2023

Via Benzinga

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Are On Fire Today ↗

August 08, 2023

Novo Nordisk's popular weight loss drug also confers a significant cardioprotective effect, according to a new study.

Via The Motley Fool

Lilly Shares Up On Versanis Deal Amid Weight-Loss Drug Gold Rush

July 24, 2023

A bid to acquire Versanis boosts Eli Lilly & Co. by 2.80% in the past week, as the competition to develop the most effective weight-loss drug intensifies.

Via MarketBeat

3 Small-Cap Stocks That Could Be Big-Time Winners ↗

July 22, 2023

These stocks come with significant risks. But they could generate huge returns over time.

Via The Motley Fool

The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly? ↗

July 13, 2023

An overweight world is hungry for new treatments. For now, two companies own the market.

Via Investor's Business Daily

3 Top Biotech Stocks Defying the Bear Market ↗

July 13, 2023

Each has the potential to dramatically outperform the market.

Via The Motley Fool

2 Hot Stocks Up 30% This Year That Wall Street Thinks Can Still Go Higher ↗

July 12, 2023

Are analysts right to be so bullish about these stocks?

Via The Motley Fool

The 3 Best Momentum Stocks to Buy in July ↗

July 07, 2023

For those who identify the right shares at the right time, the rewards of momentum stocks far outstrip those of their competitors.

Via InvestorPlace

The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023 ↗

June 29, 2023

If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead.

Via InvestorPlace

Better Buy: Nano-X Imaging vs. Viking Therapeutics ↗

June 29, 2023

Which healthcare stock is the better option for growth investors?

Via The Motley Fool

Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says ↗

June 28, 2023

Tuesday, Terns Pharmaceuticals Inc (NASDAQ: TERN) shares lost more than 25% of their value due to investor pressure it faced after Eli Lilly And Co (NYSE: LLY) announced data from retatrutide that was...

Via Benzinga

Snowflake, Beazer Homes, Joby Aviation And Other Big Stocks Moving Higher On Wednesday ↗

June 28, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Viking Therapeutics Is Plunging Today ↗

June 27, 2023

The biotech's shares are being negatively impacted today by mid-stage data for a competing weight loss drug.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 27, 2023

Via Benzinga

Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 27, 2023

Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.

Via Benzinga

Why Viking Therapeutics Stock Is Crashing Today ↗

June 26, 2023

Investors seem concerned about the company's competitive positioning in weight loss.

Via The Motley Fool

2 Low-Priced Stocks That Could Make You Richer ↗

June 26, 2023

These two low-priced healthcare stocks could skyrocket within the next 12 months.

Via The Motley Fool

3 Biotech Stocks to Buy as Companies Ink Major Deals ↗

June 22, 2023

Pharmaceutical and biotech companies will soon face generic competition, creating big opportunity for these top biotech stocks to buy.

Via InvestorPlace

7 Healthcare Stocks to Make You the Millionaire Next Door ↗

June 21, 2023

For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy.

Via InvestorPlace

After Blasting Off 881% in 1 Year, Is Viking Therapeutics Still a Good Buy? ↗

June 20, 2023

The risks are high, and the rewards are uncertain for new buyers.

Via The Motley Fool

< Previous 1 2

...

28 29 30 31 32 33 34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.